US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 49.130
  • -0.230-0.47%
Close Apr 26 16:00 ET
  • 49.100
  • -0.030-0.06%
Post 19:12 ET
122.65BMarket Cap25.46P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanofi Earnings Date

Currency: EUR

Period

Q1 FY2024 Earnings

Apr 25, 2024

Revenue(YoY)

11.12B

+2.35%
EPS(YoY)

0.46

-43.13%
Analyst Rating

Buy

Apr 23, 2024

Sanofi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 25, 20242024/Q3-- / 12.969B--
Jul 25, 20242024/Q2-- / 10.452B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--
--2023/Q311.964B / 12.016B--
Jul 28, 20232023/Q29.965B / 10.072B--
Apr 27, 20232023/Q110.222B / 10.288B--
Feb 3, 20232022/Q410.725B / 10.970B--
Oct 28, 20222022/Q312.482B / 12.045B--
Jul 28, 20222022/Q210.116B / 9.830B--
DatePeriodRevenue/EstimateEarnings Call
Oct 25, 20242024/Q3-- / 12.969B--
Jul 25, 20242024/Q2-- / 10.452B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--
--2023/Q311.964B / 12.016B--
Jul 28, 20232023/Q29.965B / 10.072B--
Apr 27, 20232023/Q110.222B / 10.288B--
Feb 3, 20232022/Q410.725B / 10.970B--
Oct 28, 20222022/Q312.482B / 12.045B--
Jul 28, 20222022/Q210.116B / 9.830B--

Unlock Free Earnings Estimates

Sanofi Earnings Reports

  • Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance

    Apr 25 10:55 ET

  • Sanofi | 20-F: Registration statement / Annual report / Transition report

    Feb 23 11:20 ET

  • Sanofi | 6-K: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline

    Feb 1 09:46 ET

  • Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 28, 2023 15:35 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 23, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg